NCT04329949Phase 3Terminated

Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Study sponsor: Corcept Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2021-08-23Actual
Enrollment · participants43Actual
Source updated2023-11-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview